Alexza Pharmaceuticals Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Alexza Pharmaceuticals Inc. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$4.25 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2016-05-13
- Alexza Pharmaceuticals Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-03-31 was -$4.25M.
- Alexza Pharmaceuticals Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2015-12-31 was -$3.54M.
- Alexza Pharmaceuticals Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2015-09-30 was -$7.47M.
- Alexza Pharmaceuticals Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2015-06-30 was -$8.14M.
- Alexza Pharmaceuticals Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$31.88M.
- Alexza Pharmaceuticals Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$41.50M.
- Alexza Pharmaceuticals Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was -$612.00K.
- Alexza Pharmaceuticals Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2012 was -$18.24M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2016-03-31 | -$4.25M 10-Q · filed 2016-05-13 | -$7.79M derived: sum of 2 quarters · filed 2016-05-13 | -$15.26M derived: sum of 3 quarters · filed 2016-05-13 | -$23.40M derived: sum of 4 quarters · filed 2016-05-13 |
| 2015-12-31 | -$3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | -$11.01M derived: sum of 2 quarters · filed 2016-03-28 | -$19.15M derived: sum of 3 quarters · filed 2016-03-28 | -$31.88M 10-K · filed 2016-03-28 |
| 2015-09-30 | -$7.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$15.61M derived: sum of 2 quarters · filed 2015-11-05 | -$28.34M 10-Q · filed 2015-11-05 | -$35.45M derived: sum of 4 quarters · filed 2016-05-13 |
| 2015-06-30 | -$8.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$20.88M 10-Q · filed 2015-08-06 | -$27.98M derived: sum of 3 quarters · filed 2016-05-13 | -$37.77M derived: sum of 4 quarters · filed 2016-05-13 |
| 2015-03-31 | -$12.73M 10-Q · filed 2016-05-13 | -$19.84M derived: sum of 2 quarters · filed 2016-05-13 | -$29.63M derived: sum of 3 quarters · filed 2016-05-13 | -$43.08M derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | -$7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | -$16.89M derived: sum of 2 quarters · filed 2016-03-28 | -$30.35M derived: sum of 3 quarters · filed 2016-03-28 | -$41.50M 10-K · filed 2016-03-28 |
| 2014-09-30 | -$9.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$23.25M derived: sum of 2 quarters · filed 2015-11-05 | -$34.40M 10-Q · filed 2015-11-05 | |
| 2014-06-30 | -$13.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$24.61M 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | -$11.15M 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | -$612.00K 10-K · filed 2016-03-28 | |||
| 2013-09-30 | $10.05M 10-Q · filed 2014-11-05 | |||
| 2013-06-30 | $20.01M 10-Q · filed 2014-08-07 | |||
| 2012-12-31 | -$18.24M 10-K · filed 2015-03-13 |